Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Apellis Pharmaceuticals, Inc. (APLS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-KS-1/A
Revenues  66.6250.60.00.00.00.00.08.4
            Revenue growth  -73.4%     -100.0%261.6%
Cost of goods sold  0.20.00.00.00.00.00.016.8
Gross profit  66.4250.60.00.00.00.00.0-8.4
            Gross margin  99.7%100.0%     -100.0%
Selling, general and administrative   [+]176.8139.467.022.610.54.36.42.9
Research and development  345.9299.9221.0105.340.323.013.7 
Other operating expenses  80.025.1     0.0
EBITDA   [+]-534.9-213.1-287.8    -11.3
            EBITDA margin  -803.6%-85.0%     -134.7%
Depreciation and amortization  1.40.60.2    0.0
EBIT   [+]-536.3-213.7-288.0-127.9-50.8-27.3-20.1-11.3
            EBIT margin  -805.7%-85.3%     -134.8%
Non-recurring items   [+]      26.5 
Interest expense, net   [+]12.825.80.2-0.40.1-0.1-0.1 
Other income (expense), net   [+]-196.9-103.5-16.50.0-0.10.00.00.1
Pre-tax income  -746.0-343.0-304.7-127.5-51.0-27.1-46.5-11.2
Income taxes  0.41.80.00.00.00.00.0-0.4
            Tax rate    0.0%0.0%0.0%0.0%0.0%3.9%
Net income  -746.4-344.9-304.7-127.5-51.0-27.1-46.5-10.8
            Net margin  -1121.3%-137.6%     -128.7%
   
Basic EPS   [+]($8.84)($4.59)($4.90)($2.34)($3.68)($3.22)($8.03)($1.10)
Diluted EPS   [+]($8.84)($4.59)($4.90)($2.34)($3.68)($3.22)($8.03)($1.10)
   
Shares outstanding (basic)   [+]84.475.262.254.413.98.45.89.8
Shares outstanding (diluted)   [+]84.475.262.254.413.98.45.89.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy